We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current GRAL market cap is 1.01B. The company's latest EPS is USD -43.6206 and P/E is -0.69.
Quarter End | Sep 2024 |
---|---|
USD (US$) | |
Total Revenue | 28.65M |
Operating Income | -183.51M |
Net Income | -125.69M |
Year End 31 December 2023 | 2023 |
---|---|
USD (US$) | |
Total Revenue | 93.11M |
Operating Income | -1.52B |
Net Income | -1.47B |
Quarter End | Sep 2024 |
---|---|
USD (US$) | |
Total Assets | 3.12B |
Total Liabilities | 530.32M |
Total Equity | 2.59B |
Year End 31 December 2023 | 2023 |
---|---|
USD (US$) | |
Total Assets | 3.91B |
Total Liabilities | 267.63M |
Total Equity | 3.65B |
Market Cap | 1.01B |
Price to Earnings Ratio | -0.69 |
Price to Sales Ratio | 10.92 |
Price to Cash Ratio | 10.45 |
Price to Book Ratio | 0.28 |
Dividend Yield | - |
Shares Outstanding | 33.6M |
Average Volume (1 week) | 1.39M |
Average Volume (1 Month) | 1.05M |
52 Week Change | 61.03% |
52 Week High | 31.59 |
52 Week Low | 12.33 |
Spread (Intraday) | 1.35 (4.41%) |
Company Name | GRAIL Inc |
Address |
corporation trust center wilmington, delaware 19801 |
Website | https://grail.com |
Industry | medical laboratories (8071) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions